Show Summary Details
Page of

Chronic obstructive pulmonary disease and asthma 

Chronic obstructive pulmonary disease and asthma
Chronic obstructive pulmonary disease and asthma

Jeroen Douwes

, Marike Boezen

, Collin Brooks

, and Neil Pearce

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2022. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 26 May 2022

Chronic obstructive pulmonary disease (COPD) and asthma are highly prevalent, non-malignant respiratory conditions which have increased dramatically in the past few decades, both in Western and non-Western societies. They have a profound impact on quality of life for patients and their families, and COPD is also a major cause of death. The major causal risk factor for COPD is tobacco smoke, although a substantial proportion of COPD is also caused by occupational exposures and indoor environmental exposures, particularly in middle- and low-income countries. Although cigarette smoking is the major risk factor for COPD, usually only a relatively small proportion of smokers develop COPD, a pattern which may be explained by genetic susceptibility factors. Like asthma, COPD prevalence differs greatly between countries and these differences are not explained by cigarette smoking alone. Nonetheless, smoking cessation is the most effective way to halt the global increases in the prevalence of COPD. Improved ventilation measures to reduce indoor pollutants in houses of most middle- and low-income countries are also effective ways to reduce morbidity and mortality. A large number of potential risk factors for asthma have been identified including genetic factors, allergen exposure, demographic parameters, diet, obesity, indoor and outdoor pollution, passive and active tobacco smoking, occupational exposures, viral infections, and the use of paracetamol (acetaminophen). However, none of these risk factors on their own can explain the substantial global increases in asthma prevalence observed in the last few decades and the significant differences in asthma prevalence between countries. Interestingly, recent studies have shown that the increase in asthma prevalence appears to have levelled off in many high-income countries, with some even showing a decrease. The reasons for this are unclear. Understanding why these changes in prevalence are occurring, and ascertaining which elements of the ‘package’ of century economic development and lifestyle changes are responsible, is essential in order to develop effective intervention programmes to halt the current global asthma epidemic.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.